Eyecare

Analyst reaffirms buy rating on Alcon despite failed STAAR merger

A Seeking Alpha analyst has reaffirmed a buy rating on Alcon (ALC) stock, highlighting its eyecare portfolio amid the abandoned acquisition of STAAR Surgical. The assessment points to resilience against market shocks and positive earnings forecasts for FY26.

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.

Kataa